Page last updated: 2024-09-03

foropafant and bwa 4c

foropafant has been researched along with bwa 4c in 1 studies

Compound Research Comparison

Studies
(foropafant)
Trials
(foropafant)
Recent Studies (post-2010)
(foropafant)
Studies
(bwa 4c)
Trials
(bwa 4c)
Recent Studies (post-2010) (bwa 4c)
374174016

Protein Interaction Comparison

ProteinTaxonomyforopafant (IC50)bwa 4c (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)0.1976
Arachidonate 5-lipoxygenase-activating proteinHomo sapiens (human)0.11
Prostaglandin G/H synthase 1Homo sapiens (human)3.2
Prostaglandin G/H synthase 2Homo sapiens (human)3.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leduc, D; Pretolani, M; Vargaftig, BB; Zuany-Amorim, C1

Other Studies

1 other study(ies) available for foropafant and bwa 4c

ArticleYear
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
    British journal of pharmacology, 1993, Volume: 110, Issue:2

    Topics: Animals; Benzeneacetamides; Cetirizine; Cycloheximide; Dexamethasone; Eosinophils; Histamine Release; Hydroxamic Acids; Indomethacin; Kinetics; Leukocyte Count; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Peritoneal Cavity; Peritonitis; Platelet Activating Factor; T-Lymphocytes; Tacrolimus; Terfenadine; Thiazoles; Zymosan

1993